miR-122 inhibition in a human liver organoid model leads to liver inflammation, necrosis, steatofibrosis and dysregulated insulin signaling

Document Details

Document Type
Pub Defense Publication
Publication Date
Jul 19, 2018
Source ID
10.1371/journal.pone.0200847

Entities

People

  • Anthony Atala
  • Colin E. Bishop
  • Herbert L. Bonkovsky
  • Hossein Sendi
  • Ivy Mead
  • Kenneth Koch
  • Marjan Mehrab-mohseni
  • Meimei Wan

Organizations

  • Defense Threat Reduction Agency
  • National Institutes of Health